Quinolone tolerance in Escherichia coli due to defects in the adenosine ribonucleotides de novo biosynthesis pathway
mLife · 2026-04 · 5 (2) · 217-228
DOI: 10.1002/mlf2.70059 ↗Kurz gefasst
Fachartikel in der Zeitschrift mLife, online erschienen am 16.04.2026. Verfasst von Weiwei Zhu und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Vaccines for Infectious Diseases, Xiang-An Biomedicine Laboratory, National Innovation Platform for Industry-Education Integr…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Central carbon metabolism is thought to link reactive oxygen species (ROS) with antibiotic‐mediated bacterial death. During enrichment screening of Escherichia coli with the first‐generation quinolone oxolinic acid, unstable antibiotic‐tolerant mutants containing deficiencies in purB were obtained. Examination of a stable deletion mutant of purA , a gene functionally related to purB , revealed reduced lethality of oxolinic acid and ciprofloxacin. This deletion mutation had little effect on the minimal inhibitory concentration (MIC) of quinolones, thereby demonstrating that the observed protection from killing was attributable to antibiotic tolerance. AMP synthesis was blocked by the Δ purA mutation, and ciprofloxacin tolerance was reversed by exogenous AMP supplementation. Because AMP is a precursor of ATP, interference with ATP synthesis occurs in the Δ purA mutant. RNA‐Seq analysis showed that, prior to antibiotic stress, transcript levels of NADH:quinone oxidoreductase genes were reduced by the purA deficiency, thereby predisposing E. coli to antibiotic tolerance through reduced respiration. During ciprofloxacin exposure, the purA deficiency also suppressed the surge in expression of tricarboxylic acid (TCA) cycle and ATP synthesis genes, as well as the accumulation of intracellular ATP and ROS. Thus, wild‐type PurA, and by extension the downstream enzyme PurB, directs AMP toward an antibiotic‐mediated, ROS‐dependent death pathway. Overall, defects in PurA/PurB‐mediated adenosine ribonucleotides de novo biosynthesis reveal a novel quinolone tolerance mechanism that is initiated outside central carbon metabolism; tolerance is likely attributable to a limited supply of AMP, resulting in reduced ATP synthesis and suppression of ROS accumulation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Vaccines for Infectious Diseases, Xiang-An Biomedicine Laboratory, National Innovation Platform for Industry-Education Integration in Vaccine Research, Department of Laboratory Medicine, School o…
- Center of Clinical Laboratory, Zhongshan Hospital, School of Medicine Xiamen University Xiamen China.
- Public Health Research Institute and Department of Microbiology, Biochemistry & Molecular Genetics, New Jersey Medical School Rutgers University Newark New Jersey USA.
ORCID-Profile: Weiwei Zhu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhu, W., Nong, Y., Su, J., Yang, J., Ma, L., Xue, Y., Wang, D., Niu, J., Drlica, K., & Zhao, X. (2026). Quinolone tolerance in Escherichia coli due to defects in the adenosine ribonucleotides de novo biosynthesis pathway. mLife, 5(2), 217-228. https://doi.org/10.1002/mlf2.70059
Vancouver
Zhu W, Nong Y, Su J, Yang J, Ma L, Xue Y, et al. Quinolone tolerance in Escherichia coli due to defects in the adenosine ribonucleotides de novo biosynthesis pathway. mLife. 2026;5(2):217-228. doi:10.1002/mlf2.70059
BibTeX
@article{Zhu2026,
author = {Zhu, Weiwei and Nong, Yuejuan and Su, Jie and Yang, Jingwen and Ma, Lina and Xue, Yunxin and Wang, Dai and Niu, Jianjun and Drlica, Karl and Zhao, Xilin},
title = {Quinolone tolerance in Escherichia coli due to defects in the adenosine ribonucleotides de novo biosynthesis pathway},
journal = {mLife},
year = {2026},
volume = {5},
number = {2},
pages = {217--228},
doi = {10.1002/mlf2.70059}
}
EUVIMED